GlassScriptPhysician profile
Douglas J Ward
NPI 1396830725
$233,071.91
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145K · 2020: $44K · 2021: $22K · 2022: $22K · 2023: $17.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $172,305.39 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $25,633.59 | 2019-2022 | |
| Gilead Sciences, INC. | $21,016.60 | 2019-2022 | |
| Theratechnologies INC. | $9,457.09 | 2019-2020 | |
| Napo Pharmaceuticals INC | $3,291.90 | 2019-2022 | |
| Glaxosmithkline, LLC. | $1,022.35 | 2019 | |
| Janssen Biotech, INC. | $118.93 | 2019-2020 | |
| Janssen Products, LP | $99.95 | 2019 | |
| Antares Pharma, INC. | $40.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.35 | 2019 | |
| Pfizer INC. | $18.78 | 2019 | |
| Mayne Pharma Commercial LLC | $17.99 | 2023 | |
| Endo Pharmaceuticals INC. | $14.79 | 2019 | |
| Allergan, INC. | $12.66 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.